Bio-Rad Laboratories Class A
327 hedge funds and large institutions have $4.43B invested in Bio-Rad Laboratories Class A in 2018 Q4 according to their latest regulatory filings, with 47 funds opening new positions, 116 increasing their positions, 117 reducing their positions, and 62 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
327
Holders Change
-15
Holders Change %
-4.39%
% of All Funds
7.3%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.13%
New
47
Increased
116
Reduced
117
Closed
62
Calls
$5.48M
Puts
$8.06M
Net Calls
-$2.58M
Net Calls Change
+$236K
Top Buyers
1 |
LCS
Levin Capital Strategies
New York
|
+$130M |
2 |
Russell Investments Group
London,
United Kingdom
|
+$45.3M |
3 |
UBS AM
Chicago,
Illinois
|
+$37.2M |
4 |
TCM
TimesSquare Capital Management
New York
|
+$20.7M |
5 |
First Trust Advisors
Wheaton,
Illinois
|
+$19.5M |
Top Sellers
1 |
ACM
Atlanta Capital Management
Atlanta,
Georgia
|
-$132M |
2 |
BC
Bodenholm Capital
Stockholm,
Sweden
|
-$32.5M |
3 |
AAMU
Amundi Asset Management US
Boston,
Massachusetts
|
-$32.1M |
4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$29.9M |
5 |
Select Equity Group
New York
|
-$29.6M |